Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10952996
ALK5 inhibitors
granted -
US 10954237
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10947238
Wee1 kinase inhibitors and methods of making and using the same
granted -
US 10940141
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10941183
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10941140
IRAK inhibitors and method for making and using
granted -
US 10934274
Quinoline derivatives as TAM RTK inhibitors
granted -
US 10934332
Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
granted -
US 10934305
SHMT inhibitors
granted -
US 10934299
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
granted -
US 10932484
Inhibitory activity of acetogenins against Listeria monocytogenes
granted -
US 10934349
Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody
granted -
US 10934302
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 10933022
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10927118
Inhibitors of influenza virus replication and uses thereof
granted -
US 10927130
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10919877
Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same
granted -
US 10913753
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
granted -
US 10912779
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10913709
STAT3 inhibitor formulation
granted -
US 10912771
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10913711
Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
granted -
US 10913740
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10906914
Furoquinolinediones as inhibitors of TDP2
granted